Psychedelic Clinical Trials
Find clinical trials studying psilocybin, MDMA, ketamine and other psychedelics. Many trials are actively recruiting participants who haven't found relief from conventional treatments.
Observation of Safety and Tolerability Within 1 Year of the Use of R-ketamine / Placebo in Drug-resistant Depression
Medical University of Gdansk
Palliadelic Treatment to Reduce Psychological Distress in Persons With Advanced Gastrointestinal Cancers
University of Nebraska
Effect of Ketamine Infusion on BIS Values
University of Padova
Perioperative Multimodal General AnesTHesia Focusing on Specific CNS Targets in Patients Undergoing carDiac surgERies
Beth Israel Deaconess Medical Center
Mindfulness and Psychedelics
Milan Scheidegger
Real-World Persistence and Adherence of Ofatumumab Compared to Self-Injectable and Oral DMTs in Patients With Multiple Sclerosis
Novartis
The Effects of Sedatives on Tobacco Use Disorder Version 2
Wake Forest University Health Sciences
Efficacy, Safety, and Tolerability of COMP360 in Participants With TRD
COMPASS Pathways
The 'Wearing Off' Effect of DMT
Novartis Pharmaceuticals
PAPR: PAP + MBSR for Front-line Healthcare Provider COVID-19 Related Burnout
University of Utah
Psilocybin for the Treatment of Veterans With Post-Traumatic Stress Disorder
Ohio State University
Pharmacokinetics, Safety, and Tolerability of Intramuscular 5-MeO-DMT in Healthy Volunteers
Usona Institute
Safety and Pharmacokinetics of GH002 in Healthy Volunteers
GH Research Ireland Limited
SPL026 With or Without SSRIs in Participants With MDD
Small Pharma Ltd
Psilocybin in Adults With and Without Autism Spectrum Disorder
King's College London
Low Dose Ketamine Infusion for Analgesia in the Emergency Department to Reduce Side Effects
Summa Health System
Oral Aspirin + Ketamine as Adjunct to Oral Antidepressant Therapy for Depression
Theresa Jacob, PhD, MPH
Acute Dose-dependent Effects of DMT in Healthy Subjects
University Hospital, Basel, Switzerland
Comparison of Esketamine/Propofol and Methohexital Anesthesia for ECT
Medical University of Vienna
Psilocybin Combined With Multidisciplinary Palliative Care in Demoralized Cancer Survivors With Chronic Pain
Emory University
PsilOCD: A Pharmacological-Challenge Feasibility Study
Imperial College London
Effects of SERT Inhibition on the Subjective Response to LSD in Healthy Subjects
University Hospital, Basel, Switzerland
Feasibility Study of Oral Ketamine Versus Placebo for the Treatment of Anxiety in Patients With Pancreatic Cancer
Cedars-Sinai Medical Center
Efficacy and Safety of COMP360 Psilocybin Therapy in Anorexia Nervosa: a Proof-of-concept Study
COMPASS Pathways
Ketamine Versus Midazolam for Recurrence of Suicidality in Adolescents
University of Texas Southwestern Medical Center
Acute Effects of R- and S-MDMA in Healthy Subjects
University Hospital, Basel, Switzerland
Efficacy and Pharmacokinetic-Pharmacodynamic Relationship of Intranasally Administered Sufentanil, Ketamine, and CT001
Cessatech A/S
The Efficacy of a Subanesthetic Doses of IV Ketamine in the Treatment Drug Resistant Epilepsy
Madeline Fields
A Dose-Finding Study of MM120 (LSD D-Tartrate) for the Treatment of Anxiety Symptoms
Definium Therapeutics US, Inc.
Maintenance Ketamine Infusions for Treatment-Resistant Bipolar Depression
Joshua Rosenblat
Perceptions of MDMA-Assisted Therapy Among Veterans With PTSD
Albany Research Institute, Inc.
Ketamine Low dOse Evaluation on Morphine Consumption in Traumatic Patient
Assistance Publique Hopitaux De Marseille
A Study of a Psilocybin Analog (CYB003) in Healthy Participants With and Without Major Depressive Disorder
Cybin IRL Limited
Food Effects on Bioavailability of MDMA in Healthy Volunteers
Resilient Pharmaceuticals
Anhedonia, Development, and Emotions: Phenotyping and Therapeutics
Erika Forbes
Ketamine for Treatment-Resistant Bipolar Disorder
Joshua Rosenblat
Effects of Psilocybin in Post-Treatment Lyme Disease
Johns Hopkins University
An Evaluation of Psilocybin's Effect on Cardiac Repolarization and the Effect of Food on Psilocybin's Pharmacokinetics
Usona Institute
The Safety and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder
COMPASS Pathways
Investigation of Intranasal Ketamine Related Changes in Attentional Brain Networks With Functional and Structural MRI
Rupert Lanzenberger
Effects of Ketamine on ERP/EEG Measures in Healthy Volunteers
ERP Biomarker Qualification Consortium
Effects of Stimulants on Behavioral and Neural Markers of Social Motivation, Ability, and Neural Markers of Social Function
University of Chicago
Elucidating the Neurocircuitry of Irritability With High-Field Neuroimaging to Identify Novel Therapeutic Targets
University of Texas Southwestern Medical Center
Neural Correlates of Ketamine's Anti-suicidal Effects in Bipolar Depression
Centre for Addiction and Mental Health
Effects of LSD on Neuroplasticity in Healthy Subjects
University of Fribourg
Ketamine for Postoperative Avoidance of Depressive Symptoms: The K-PASS Feasibility Trial
Washington University School of Medicine
Social Anxiety MDMA-Assisted Therapy Investigation
Jason B Luoma
Tolerance and Potential Synergistic Effect of the Combination of Intranasal Esketamine and Non-selective MAOI
University Hospital, Strasbourg, France
Browse by Condition
View all conditions →How to Join a Clinical Trial
Clinical trials are research studies that test new treatments. Participating can give you access to cutting-edge therapies while contributing to medical science. Each trial has specific eligibility criteria based on the research goals.
1. Review
Read the trial details, eligibility criteria, and what participation involves.
2. Contact
Reach out to the study team using the contact information provided.
3. Screen
Complete the screening process to determine if you're eligible.